text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2021년 06월 30일\n)\n(단위 : 천원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n케이아이씨공업기계 (장가항) 유한공사\n비상장\n2017.10.27\n해외사업\n1,650,000\n139,613\n100.0\n1,197,643\n-\n-\n-\n139,613\n100.0\n1,197,643\n1,536,222\n37,823\n에이프로젠제약(주)\n상장\n2018.06.13\n신규사업\n129,754,333\n179,342,916\n45.0\n199,322,256\n-\n-\n-\n179,342,916\n45.0\n199,322,256\n490,788,912\n2,873,481\n\xa0에이프로젠아이앤씨㈜ (주1)\n비상장\n2021.06.01\n물적분할\n19,101,515\xa0\n1,800,000\n100.0\n19,101,515\n-\n-708,424\n-\n1,800,000\n100.0\n18,393,091\n19,169,763\n-59,757\n(주)에이프로젠바이오로직스\n비상장\n2018.06.20\n신규사업\n117,500,000\n58,750,000\n38.6\n106,572,500\n-\n-\n-\n58,750,000\n38.6\n106,572,500\n369,460,356\n-31,171,978\n(주)에이프로젠\n비상장\n2018.03.08\n투자\n40,407,635\n2,221,944\n4.3\n58,999,279\n-\n-\n-\n2,221,944\n4.3\n58,999,279\n213,764,839\n-80,664,776\nVina Securities Joint Stock Company\n비상장\n2019.08.22\n해외사업\n2,064,589\n3,940,000\n14.4\n326,110\n-\n-\n-\n3,940,000\n14.4\n326,110\n1,940,010\n-3,519,131\n비보존헬스케어(주2)\n상장\n2021.02.03\n투자\n13,150,685\n6,849,315\n4.3\n13,150,685\n-43,322\n-70,118\n-2,225,008\n6,805,993\n4.3\n10,855,559\n193,005,212\n-5,189,552\n합 계\n254,043,788\n-\n398,669,988\n-43,322\n-778,542\n-2,225,008\n253,000,466\n-\n395,666,438\n1,289,665,314\n-117,693,890\n(주1) 당반기 중 회사의 단열사업부분을 물적분할하였으며, 동 분할로 인하여 이전된 순자산 장부금액을 분할신설법인인 에이프로젠아이앤씨㈜의 취득원가로 인식했습니다.(주2) 기타포괄손익반영\n']"
